Insider Transactions in Q4 2021 at Ventyx Biosciences, Inc. (VTYX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 25
2021
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
625,000
+30.71%
|
$10,000,000
$16.0 P/Share
|
|
Oct 25
2021
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
785,303
+50.0%
|
-
|
|
Oct 25
2021
|
Aaron Royston Director |
BUY
Open market or private purchase
|
Indirect |
312,500
+7.25%
|
$5,000,000
$16.0 P/Share
|
|
Oct 25
2021
|
Aaron Royston Director |
BUY
Conversion of derivative security
|
Indirect |
3,684,769
+50.0%
|
-
|
|
Oct 25
2021
|
Sheila Gujrathi |
BUY
Conversion of derivative security
|
Direct |
32,897
+50.0%
|
-
|
|
Oct 25
2021
|
Somu Subramaniam |
BUY
Conversion of derivative security
|
Indirect |
16,892,528
+50.0%
|
-
|
|
Oct 25
2021
|
Nsv Investments I, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
16,892,528
+50.0%
|
-
|
|
Oct 25
2021
|
Ven Bio Global Strategic Fund Iii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
312,500
+7.25%
|
$5,000,000
$16.0 P/Share
|
|
Oct 25
2021
|
Ven Bio Global Strategic Fund Iii, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
3,684,769
+50.0%
|
-
|